Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 11, 2025 07:30 ET | Source: Juvena Therapeutics

Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health

Lilly taps Juvena's AI platform, the first to map the therapeutic potential of secreted proteins, to discover treatments that improve muscle health.
May 19, 2025 08:25 ET | Source: Juvena Therapeutics

Juvena Therapeutics Announces Initiation of First-in-Human Clinical Trial of JUV-161

JUV-161 is a first-in-class muscle regenerating biologic that will address myopathies starting with Myotonic Dystrophy Type 1 JUV-161 was discovered using Juvena’s proprietary JuvNET platform, an AI...